Ascentage Pharma Group International (AAPG) Stock Forecast & Price Target

$21.57 -0.33 (-1.51%)

Closing price 03:59 PM Eastern

Extended Trading

$21.79 +0.22 (+1.02%)

As of 07:49 PM Eastern

Compare

Ascentage Pharma Group International - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Buy

Based on 8 Analyst Ratings

Sell
0

Hold
0

Buy
8

Based on 8 Wall Street analysts who have issued ratings for Ascentage Pharma Group International in the last 12 months, the stock has a consensus rating of "Buy." Out of the 8 analysts, 6 have given a buy rating, and 2 have given a strong buy rating for AAPG.

Consensus Price Target

$46.67
116.35% Upside

According to the 8 analysts' twelve-month price targets for Ascentage Pharma Group International, the average price target is $46.67. The highest price target for AAPG is $51.00, while the lowest price target for AAPG is $40.00. The average price target represents a forecasted upside of 116.35% from the current price of $21.57.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for AAPG and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Ascentage Pharma Group International and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AAPG Analyst Ratings Over Time

Type	Current Forecast 5/6/25 to 5/6/26	1 Month Ago 4/6/25 to 4/6/26	3 Months Ago 2/5/25 to 2/5/26	1 Year Ago 5/6/24 to 5/6/25
Strong Buy	2 Strong Buy rating(s)	2 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	6 Buy rating(s)	5 Buy rating(s)	6 Buy rating(s)	1 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$46.67	$48.00	$48.40	N/A
Forecasted Upside	116.35% Upside	74.90% Upside	100.08% Upside	N/A
Consensus Rating	Buy	Buy	Buy	Buy

AAPG Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

AAPG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Ascentage Pharma Group International Stock vs. The Competition

Type	Ascentage Pharma Group International	Medical Companies	S&P 500
Consensus Rating Score	3.25	2.30	2.52
Consensus Rating	Buy	Hold	Moderate Buy
Predicted Upside	115.40% Upside	912.84% Upside	13.98% Upside
News Sentiment Rating	Positive News See Recent AAPG News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
4/24/2026	Deutsche Bank Aktiengesellschaft 2 of 5 stars		Initiated Coverage	Buy	$40.00	+79.05%
4/13/2026	BTIG Research 2 of 5 stars	Jeet Mukherjee Not Rated	Reiterated Rating	Buy	$48.00	+89.50%
4/6/2026	China Intl Cap Not Rated		Upgrade	Strong-Buy
1/13/2026	Rodman & Renshaw Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Buy	$48.00	+75.76%
12/15/2025	Lucid Cap Mkts Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong-Buy
12/4/2025	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Biegler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Outperform	$45.00	+48.37%
11/24/2025	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregory Renza Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$51.00	+66.45%
11/5/2025	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Biren Amin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Overweight	$48.00	+44.36%
3/27/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Cheng Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Overweight

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 10:17 PM ET.

AAPG Forecast - Frequently Asked Questions

: According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for Ascentage Pharma Group International is $46.67, with a high forecast of $51.00 and a low forecast of $40.00.
: 8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ascentage Pharma Group International in the last twelve months. There are currently 6 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AAPG shares.
: According to analysts, Ascentage Pharma Group International's stock has a predicted upside of 116.35% based on their 12-month stock forecasts.
: Over the previous 90 days, Ascentage Pharma Group International's stock had 2 upgrades by analysts.
: Ascentage Pharma Group International has been rated by research analysts at BTIG Research, China Intl Cap, and Deutsche Bank Aktiengesellschaft in the past 90 days.
: Analysts like Ascentage Pharma Group International more than other "medical" companies. The consensus rating for Ascentage Pharma Group International is Buy while the average consensus rating for "medical" companies is Hold. Learn more on how AAPG compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Ascentage Pharma Group International Recommendations

This page (NASDAQ:AAPG) was last updated on 5/6/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ascentage Pharma Group International (AAPG) Stock Forecast & Price Target

Ascentage Pharma Group International - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

AAPG Analyst Ratings Over Time

AAPG Analyst Recommendations By Month

AAPG Price Targets by Month

Ascentage Pharma Group International Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

AAPG Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Ascentage Pharma Group International Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ascentage Pharma Group International (AAPG) Stock Forecast & Price Target

Ascentage Pharma Group International - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

AAPG Analyst Ratings Over Time

AAPG Analyst Recommendations By Month

AAPG Price Targets by Month

Ascentage Pharma Group International Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

AAPG Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Ascentage Pharma Group International Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools